Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, S Ntoufa, E Tausch, XJ Yan, T Shanafelt, K Plevova, M Boudjogra, D Rossi, Z Davis, A Navarro, Yorick Sandberg, FJ Vojdeman, L Scarfo, N Stavroyianni, A SudarikovS Veronese, T Tzenou, T Karan-Djurasevic, M Catherwood, D Kienle, M Chatzouli, M Facco, J Bahlo, C Pott, LB Pedersen, L Mansouri, KE Smedby, CC Chu, V Giudicelli, MP Lefranc, P Panagiotidis, G Juliusson, A Anagnostopoulos, I Vlahavas, D Antic, L Trentin, M Montillo, C Niemann, H Dohner, Ton Langerak, S Pospisilova, M Hallek, E Campo, N Chiorazzi, N Maglaveras, D Oscier, G Gaidano, DF Jelinek, S Stilgenbauer, I Chouvarda, N Darzentas, C Belessi, F Davi, A Hadzidimitriou, R Rosenquist, P Ghia, K Stamatopoulos

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5292-5301
Number of pages10
JournalClinical Cancer Research
Volume23
Issue number17
DOIs
Publication statusPublished - 2017

Cite this